An international team of scientists today announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths.
“We’re changing the paradigm for research,” said Josh Denny, M.D.,
All of Us’s chief executive officer. “Participants are our most important partners in this effort, and we know many of them are eager to get their genetic results and learn about the science they’re making possible. We’re working to provide that valuable information in a responsible way.”
The program’s in-depth genetic analyses include both whole genome sequencing and genotyping. Whole genome sequencing focuses on the more than 3 billion base pairs in the human genome, while genotyping looks at millions of genetic variants focused on people’s most common genetic differences.
All of Us Precision Medicine Program Returns First Genetic Results healthitanalytics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthitanalytics.com Daily Mail and Mail on Sunday newspapers.